Gulf Medical Projects Company — Cyborg Score 8/10

Strategic Profile

GMPC maintains a dual business model combining healthcare services with investment operations. The company has demonstrated exceptional earnings growth of 72% year-over-year with exceptional three-year cumulative EPS growth of 208%, positioning it as an outperformer relative to regional healthcare peers with a strong dividend yield of 7.39%.

Cyborg Score Rationale

GMPC exhibits robust financial fundamentals with strong earnings growth, healthy profit margins (11.5% TTM), low debt-to-equity (0.65%), and consistent dividend payments. Recent quarterly earnings show volatility but positive momentum, supported by a solid balance sheet with AED 1.4B in total assets.

Top Insights

• Exceptional earnings growth: 72% YoY EPS growth with 208% cumulative three-year gains demonstrates operational excellence
• Strong cash generation: Latest quarter net income of AED 34.98M (up 56% QoQ) indicates accelerating profitability
• Attractive dividend profile: 7.39% dividend yield with AED 0.15 per share demonstrates capital returns to shareholders
• Dual revenue model: Healthcare services segment paired with investment holdings provides diversification and financial stability

Named Competitors

• Hospital Operations & Healthcare Services — Multi-specialty hospital chain in GCC region
• Telehealth & Home Care Services — Healthcare facilities provider in UAE
• Healthcare Investment — Private hospital network in Gulf region

Recent Developments

• (May 2025) Q1 2025 financial results published with Board meeting held
• (2024) H1-24 growth delivered in financial results reflecting operational expansion
• (2023) Full-year profits exceeded AED 75M with shareholders approving AED 70M in dividends

Open the full interactive Gulf Medical Projects Company report

30-page strategic research, 15-min analyst-debate audio briefing, full Cyborg Score breakdown across 11 dimensions.